Market Tracker

11/28 11:46am ET
213.70
Real-Time Quote
 -0.30 / -0.14%
Today’s Change
94.98
Today|||52-Week Range
214.64
+92.38%
Year-to-Date

Today’s Trading

Previous close214.00
Today’s open214.09
Day’s range213.56 - 214.64
Volume516,794
Average volume (3 months)2,929,500
Market cap$63.8B
Dividend yield0.09%
Data as of 11:31am ET, 11/28/2014

Growth & Valuation

Earnings growth (last year)+18.75%
Earnings growth (this year)+32.11%
Earnings growth (next 5 years)+20.50%
Revenue growth (last year)+8.37%
P/E ratio49.9
Price/Sales5.24
Price/Book9.85

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.19+0.43%
ACTActavis-0.70-0.26%
LLYEli Lilly and Co+0.90+1.34%
VRXValeant Pharmaceutic...+1.45+1.00%
Data as of 11:46am ET, 11/28/2014

Financials

Next reporting dateFebruary 4, 2015
EPS forecast (this quarter)$1.83
Annual revenue (last year)$6.3B
Annual profit (last year)$1.3B
Net profit margin20.17%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
David E. I. Pyott
President
Douglas S. Ingram
Corporate headquarters
Irvine, California

Forecasts